Stockscreener 앱 받기
7.69
3.92%
0.29
Exicure Inc 주식(XCUR)의 최신 뉴스
Momentum divergence signals in Exicure Inc. chartHigh Return Strategy with Low Risk - Newser
Multi asset correlation models including Exicure Inc.Predictive Short-Term Market Reversal Alerts - Newser
What risks could impact Exicure Inc. stock performanceSwing Trade Picks with High Potential - Newser
Why Exicure Inc. stock attracts strong analyst attentionROI Focused Watchlist with Trade Confidence - Newser
Exicure Inc. stock daily chart insightsSmart Stock Forecast Using AI Algorithms - Newser
Using data models to predict Exicure Inc. stock movementReal Time Screener for Growth Trades - Newser
Exicure Regains Nasdaq Compliance, Files Q1 2025 Form 10-Q - AInvest
Historical volatility pattern of Exicure Inc. visualizedFree Access to Real-Time Trade Insights - Newser
Exicure, Inc. shares fall 1.97% premarket after regaining compliance with Nasdaq listing rules. - AInvest
Exicure, Inc. (Nasdaq: XCUR) Regains Compliance with Nasdaq Filing Requirements - BioSpace
Will Exicure Inc. outperform the marketFree Triple Return Setup with Risk Control - Newser
Exicure Regains Nasdaq Compliance as of July 2025 - TipRanks
Exicure Regains Nasdaq Compliance After Filing Required Periodic Reports. - AInvest
Exicure, Inc. shares fall 1.32% after-hours after regaining compliance with Nasdaq listing rules. - AInvest
Exicure Regains Nasdaq Compliance, Announces New Focus on Strategic Alternatives - AInvest
What Did We Discover About Insider Trading At Exicure Inc (NASDAQ: XCUR)? - stocksregister.com
How does Exicure Inc. compare to its industry peersExplosive market performance - Jammu Links News
Is it the right time to buy Exicure Inc. stockAchieve rapid portfolio appreciation today - Jammu Links News
When is Exicure Inc. stock expected to show significant growthConsistent triple returns - Jammu Links News
Exicure Inc. Stock Analysis and ForecastSuperior stock selection - Jammu Links News
Is Exicure Inc. stock overvalued or undervaluedGet alerts on high-potential market moves - Jammu Links News
Is Exicure Inc. a good long term investmentMaximize gains with strategic stock entries - Jammu Links News
Published on: 2025-08-03 12:31:07 - Jammu Links News
Exicure, Inc. (NASDAQ:XCUR) Short Interest Update - Defense World
Published on: 2025-08-03 09:06:10 - Jammu Links News
Why is Exicure Inc. stock attracting strong analyst attentionCapitalize on strategic market trends - Jammu Links News
How does Exicure Inc. generate profit in a changing economyPhenomenal capital appreciation - Jammu Links News
Exicure Completes the Last Patient, Last Visit in Phase 2 Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant - Lelezard
Exicure's GPC-100: A Game-Changer in Stem Cell Mobilization with Near-Term Data Catalysts - AInvest
Custom strategy builders for tracking Exicure Inc.AI Triggered Buy Zone Forecast System - Newser
Exicure's GPC-100: A High-Stakes Gamble in Myeloma Stem Cell Mobilization - AInvest
Analyzing Exicure Inc. with multi timeframe chartsTechnical Setup and Return Forecast Engine - Newser
What institutional investors are buying Exicure Inc. stockChart Pattern Updates With High Returns - Jammu Links News
Stocks to Watch: Exicure, TTEC - MarketWatch
Exicure completes last patient in Phase 2 GPC-100 combo trial - TipRanks
Exicure stock surges after completing Phase 2 trial enrollment By Investing.com - Investing.com Nigeria
Exicure stock surges after completing Phase 2 trial enrollment - Investing.com
Revolutionary 45-Minute Stem Cell Treatment Completes Phase 2 Trial, Replacing Overnight Protocol - Stock Titan
0.10%
0.21%
자본화:
|
볼륨(24시간):